2-((pyridin-4-ylmethyl)amino)-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4(3H)-one

ID: ALA5196898

PubChem CID: 168287220

Max Phase: Preclinical

Molecular Formula: C16H16N4OS

Molecular Weight: 312.40

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=c1[nH]c(NCc2ccncc2)nc2sc3c(c12)CCCC3

Standard InChI:  InChI=1S/C16H16N4OS/c21-14-13-11-3-1-2-4-12(11)22-15(13)20-16(19-14)18-9-10-5-7-17-8-6-10/h5-8H,1-4,9H2,(H2,18,19,20,21)

Standard InChI Key:  BVKWYXYHZIWKHL-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 22 25  0  0  0  0  0  0  0  0999 V2000
   -3.7828   -0.2428    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0682    0.1696    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3539   -0.2428    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3539   -1.0677    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0682   -1.4802    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7828   -1.0677    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5693   -1.3227    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5693    0.0120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0845   -0.6554    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2338    0.7655    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4133    0.8518    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0714    0.1843    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2640   -0.5692    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6464    1.4802    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.8966    0.1843    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.3092   -0.5302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1345   -0.5302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5473    0.1842    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3701    0.1835    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7828   -0.5312    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3735   -1.2431    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5489   -1.2479    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  3  2  1  0
  4  3  2  0
  5  4  1  0
  1  6  1  0
  6  5  1  0
  4  7  1  0
  3  8  1  0
  8  9  2  0
  9  7  1  0
  8 10  1  0
 11 10  1  0
 12 11  1  0
 13 12  2  0
  9 13  1  0
 10 14  2  0
 12 15  1  0
 15 16  1  0
 16 17  1  0
 18 17  2  0
 19 18  1  0
 20 19  2  0
 21 20  1  0
 22 21  2  0
 17 22  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5196898

    ---

Associated Targets(Human)

PARP14 Tchem Poly [ADP-ribose] polymerase 14 (380 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 312.40Molecular Weight (Monoisotopic): 312.1045AlogP: 2.87#Rotatable Bonds: 3
Polar Surface Area: 70.67Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 10.91CX Basic pKa: 4.23CX LogP: 2.81CX LogD: 2.81
Aromatic Rings: 3Heavy Atoms: 22QED Weighted: 0.78Np Likeness Score: -1.98

References

1. Nizi MG, Maksimainen MM, Lehtiö L, Tabarrini O..  (2022)  Medicinal Chemistry Perspective on Targeting Mono-ADP-Ribosylating PARPs with Small Molecules.,  65  (11.0): [PMID:35608571] [10.1021/acs.jmedchem.2c00281]

Source